Baxin Tong is nifedipine controlled-release tablets, Shi Huida is levamlodipine benzenesulfonate, the efficacy of the two drugs can not be directly compared, to choose the most suitable medicine for the patient. Nifedipine controlled-release tablets belong to the controlled-release technology of the preparation, the drug can be released slowly, belongs to the long-acting preparation, the antihypertensive effect is obvious, is more suitable for high blood pressure accompanied by coronary heart disease patients. Levamlodipine benzenesulfonate itself has a long half-life, also belongs to the long-acting preparation, and nifedipine controlled-release tablets belong to the same kind of drugs, the mechanism of action is similar, different patients react differently to the drug, so the efficacy of the two drugs can not be a direct comparison, depending on the patient is more suitable for which kind of drug. The adverse reactions of nifedipine controlled release tablets include reactive tachycardia, constipation, lower limb edema, facial flushing, etc. It is forbidden for patients who are allergic to the drug components, have severe aortic stenosis, or are taking oral rifampicin. Adverse reactions to levamlodipine benzenesulfonate drug constipation, gingival hyperplasia, edema of the lower extremities, facial flushing, etc. It is contraindicated in patients with hypersensitivity to the components of the drug, hypotension. Patients with hypertension should choose nifedipine controlled-release tablets or levamlodipine benzenesulfonate under the guidance of a physician, and should not use the drug without authorization.